Oculomelic amyoplasia
|
0.750 |
Biomarker
|
disease |
BEFREE |
Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family.
|
30938034 |
2019 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Dominant PIEZO2 mutations were described in patients with distal arthrogryposis type 5 and Marden-Walker syndrome.
|
27974811 |
2017 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
A family of distal arthrogryposis type 5 due to a novel PIEZO2 mutation.
|
25712306 |
2015 |
Oculomelic amyoplasia
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families.
|
24726473 |
2014 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families.
|
24726473 |
2014 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families.
|
24726473 |
2014 |
Oculomelic amyoplasia
|
0.750 |
GermlineCausalMutation
|
disease |
ORPHANET |
Both types of changes in kinetics result in increased channel activity in response to a given mechanical stimulus, suggesting that Distal Arthrogryposis Type 5 can be caused by gain-of-function mutations in PIEZO2.
|
23487782 |
2013 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Here, we describe two distinct PIEZO2 mutations in patients with a subtype of Distal Arthrogryposis Type 5 characterized by generalized autosomal dominant contractures with limited eye movements, restrictive lung disease, and variable absence of cruciate knee ligaments.
|
23487782 |
2013 |
Oculomelic amyoplasia
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Both types of changes in kinetics result in increased channel activity in response to a given mechanical stimulus, suggesting that Distal Arthrogryposis Type 5 can be caused by gain-of-function mutations in PIEZO2.
|
23487782 |
2013 |
Oculomelic amyoplasia
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Oculomelic amyoplasia
|
0.750 |
Biomarker
|
disease |
CTD_human |
|
|
|
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in PIEZO2 may lead to other phenotypes like Gordon Syndrome and Marden Walker syndrome.
|
30938034 |
2019 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Therefore, the objective of the present study was to systematically assess the effect of different pathological mutations of PIEZO2 on transcription, translation, as well as protein structure and function that contribute to GS/DA3, DA5, MWS and associated diseases based on a bioinformatics analysis using the Pubmed, ClinVar, RaptorX and Phyre2 online databases.
|
30988732 |
2019 |
MARDEN-WALKER SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PIEZO2 may cause distal arthrogryposis 3 (DA3)/Gordon syndrome (GS), DA5, Marden-Walker syndrome (MWS) and associated diseases.
|
30988732 |
2019 |
MARDEN-WALKER SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in PIEZO2 may lead to other phenotypes like Gordon Syndrome and Marden Walker syndrome.
|
30938034 |
2019 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Familial Gordon syndrome associated with a PIEZO2 mutation.
|
27714920 |
2017 |
MARDEN-WALKER SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Dominant PIEZO2 mutations were described in patients with distal arthrogryposis type 5 and Marden-Walker syndrome.
|
27974811 |
2017 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis.
|
27912047 |
2016 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family.
|
24726473 |
2014 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
CausalMutation
|
disease |
CLINVAR |
Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family.
|
24726473 |
2014 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family.
|
24726473 |
2014 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family.
|
24726473 |
2014 |
ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family.
|
24726473 |
2014 |
MARDEN-WALKER SYNDROME
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families.
|
24726473 |
2014 |
MARDEN-WALKER SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families.
|
24726473 |
2014 |